A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2020; you can also visit the original URL.
The file type is application/pdf
.
Translational Application of Circulating DNA in Oncology: Review of the Last Decades Achievements
2019
Cells
In recent years, the introduction of new molecular techniques in experimental and clinical settings has allowed researchers and clinicians to propose circulating-tumor DNA (ctDNA) analysis and liquid biopsy as novel promising strategies for the early diagnosis of cancer and for the definition of patients' prognosis. It was widely demonstrated that through the non-invasive analysis of ctDNA, it is possible to identify and characterize the mutational status of tumors while avoiding invasive
doi:10.3390/cells8101251
pmid:31615102
pmcid:PMC6829588
fatcat:g4pb6n4o5jfzrbg7wonixpgnaq